Literature DB >> 28555775

What weighs more-low compliance with self-deferral or minor medical procedures? Explaining the high rate of hepatitis C virus window-period donations in Poland.

Michal Czerwinski1, Piotr Grabarczyk2, Malgorzata Stepien1, Dorota Kubicka-Russel2, Katarzyna Tkaczuk2, Ewa Brojer2, Magdalena Rosinska1.   

Abstract

BACKGROUND: Since the introduction of nucleic acid testing (NAT) for routine blood donor screening, hepatitis C virus (HCV) RNA-only detection rates reported from Poland have been higher than in most other European countries. STUDY DESIGN AND METHODS: To examine factors that likely contribute to these window-period donations, we conducted a case-control study among 47 recently HCV-infected blood donors (cases), who gave blood between July 2002 and June 2014, and 141 controls matched by age, sex, and donation dates. Firth-corrected, conditional logistic regression models were fitted to estimate adjusted odds ratios and 95% confidence intervals. Adjusted population-attributable fractions were calculated based on the distribution of exposure among the cases.
RESULTS: On multivariate analysis, recent exposures in health care environments not routinely ascertained through predonation questionnaires were strongly associated with recently acquired HCV infection. These exposures included minor medical and dental procedures in the preceding 6 months (adjusted odds ratio, 5.77; 95 % confidence interval, 2.01-18.53). However, based on the population-attributable fraction, more important were behavioral deferrable risks that went unreported at the time of donation, such as high-risk sexual behaviors in the preceding 6 months (population-attributable fraction, 34%) or lifetime histories of drug use (population-attributable fraction, 28%).
CONCLUSIONS: This study raises questions about the effectiveness of deferral policy in excluding high-risk individuals. In addition, it provides further evidence supporting short, temporal deferrals for small medical procedures and dental treatments in Poland.
© 2017 AABB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28555775      PMCID: PMC5703057          DOI: 10.1111/trf.14163

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  33 in total

1.  Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.

Authors:  Roberta Bruhn; Nico Lelie; Michael Busch; Steven Kleinman
Journal:  Transfusion       Date:  2015-02-27       Impact factor: 3.157

2.  Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

Authors:  E L Murphy; S M Bryzman; S A Glynn; D I Ameti; R A Thomson; A E Williams; C C Nass; H E Ownby; G B Schreiber; F Kong; K R Neal; G J Nemo
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 3.  Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.

Authors:  Steven H Kleinman; Nico Lelie; Michael P Busch
Journal:  Transfusion       Date:  2009-07-21       Impact factor: 3.157

4.  Hepatitis C oubreaks in Poland in 2003-2013. Medical procedures as a dominant route of HCV transmission.

Authors:  Małgorzata Stępień; Magdalena Rosińska
Journal:  Przegl Epidemiol       Date:  2015

5.  Sexual behaviour and the risk of HCV infection.

Authors:  Andrzej Zieliński
Journal:  Przegl Epidemiol       Date:  2014

6.  Hepatitis C virus epidemiology and prevention in Polish and Swiss population - similar and contrasting experiences.

Authors:  Benjamin Sakem; Kazimierz Madaliński; Urs Nydegger; Małgorzata Stępień; Paulina Godzik; Agnieszka Kołakowska; Lorenz Risch; Martin Risch; Karolina Zakrzewska; Magdalena Rosińska
Journal:  Ann Agric Environ Med       Date:  2016-09       Impact factor: 1.447

7.  Medical procedures and the risk of iatrogenic hepatitis C infection: case-controlled study in north-eastern Poland.

Authors:  S Chlabicz; A Grzeszczuk; D Prokopowicz
Journal:  J Hosp Infect       Date:  2004-11       Impact factor: 3.926

8.  Low perception of sexual behaviours at risk for human immunodeficiency virus infection among blood donors who call the AIDS/STI Help Line in Italy.

Authors:  Vincenza Regine; Mariangela Raimondo; Laura Camoni; Maria Cristina Salfa; Pietro Gallo; Anna Colucci; Anna Maria Luzi; Barbara Suligoi
Journal:  Blood Transfus       Date:  2013-05-23       Impact factor: 3.443

9.  Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher risk, test-seeking donors attracted to blood centers? Retrovirus Epidemiology Donor Study.

Authors:  J J Korelitz; M P Busch; A E Williams
Journal:  Transfusion       Date:  1996-03       Impact factor: 3.157

10.  The relationship between multiple sex partners and anxiety, depression, and substance dependence disorders: a cohort study.

Authors:  Sandhya Ramrakha; Charlotte Paul; Melanie L Bell; Nigel Dickson; Terrie E Moffitt; Avshalom Caspi
Journal:  Arch Sex Behav       Date:  2013-02-12
View more
  5 in total

1.  Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units.

Authors:  Michal Bubinski; Agnieszka Gronowska; Pawel Szykula; Kamila Kluska; Ilona Kuleta; Emilia Ciesielska; Marcus Picard-Maureau; Elzbieta Lachert
Journal:  Transfus Med       Date:  2021-03-08       Impact factor: 2.019

2.  Significant proportion of acute hepatitis B in Poland in 2010-2014 attributed to hospital transmission: combining surveillance and public registries data.

Authors:  Małgorzata Stępień; Karolina Zakrzewska; Magdalena Rosińska
Journal:  BMC Infect Dis       Date:  2018-04-10       Impact factor: 3.090

Review 3.  Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.

Authors:  Marion C Lanteri; Felicia Santa-Maria; Andrew Laughhunn; Yvette A Girard; Marcus Picard-Maureau; Jean-Marc Payrat; Johannes Irsch; Adonis Stassinopoulos; Peter Bringmann
Journal:  Transfusion       Date:  2020-04-24       Impact factor: 3.157

4.  Seronegative hepatitis C virus infection in Polish blood donors-Virological characteristics of index donations and follow-up observations.

Authors:  Piotr Grabarczyk; Dorota Kubicka-Russel; Aneta Kopacz; Grzegorz Liszewski; Ewa Sulkowska; Paulina Zwolińska; Kazimierz Madaliński; Maciej Marek; Małgorzata Szabelewska; Ewa Świątek; Tomasz Laskus; Marek Radkowski
Journal:  J Med Virol       Date:  2019-11-21       Impact factor: 2.327

Review 5.  [Risk of transmission of blood-derived pathogens by transfusion in Poland].

Authors:  Piotr Grabarczyk; Aneta Kopacz; Ewa Sulkowska; Aleksandra Kalińska
Journal:  Acta Haematol Pol       Date:  2017-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.